Live Breaking News & Updates on Preparation Technologies

Stay updated with breaking news from Preparation technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Global Liquid Biopsy Market Review 2019-2020 and Forecast 2021-2025 with Profiles of Over 200 Competitors


Share this article
Share this article
ResearchAndMarkets.com s offering.
The scope of the report includes liquid biopsy technologies, applications, industry subsegments, biomarker technologies, major funding initiatives, patents and companies. The market sizes for liquid biopsy diagnostics are given for 2019, 2020 and 2025 (forecasted).
Liquid biopsy is creating a paradigm shift in medicine, and this is opening significant market opportunities. These market segments are particularly promising for the following liquid biopsy applications: noninvasive prenatal screening for average-risk populations; cancer screening and early detection; and recurrence monitoring for cancer patients.
Biomarker types of most interest include cell-free DNA (cfDNA), circulating tumor cells (CTCs) and exosomes. Ongoing advances in sensitive molecular technologies such as next-generation DNA sequencing (NGS) and digital polymerase chain reaction (dPCR) enable the detection of biomarker ....

United States , Diamir Bio , Cegat Gmbh , Pacific Biosciences , Cambridge Epigenetix , Twinstrand Biosciences , Telexos Gmbh , Codiak Biosciences , Capio Biosciences , Circulogene Theranostics , Laura Wood , Koninklijke Philips , Sysmex Inostics Gmbh , Apostle Inc , Burning Rock Biotech Ltd , Quantapore Inc , Biofluidica Inc , Namocell Inc , Nrichdx Inc , Dnanexus Inc , Seracare Life Sciences Inc , Id Solutions , Yikon Genomics Co Ltd , Labrinth Biotech Inc , Exosome Sciences Inc , Quantgene Inc ,